Author details

Full Name

Alastair Kent

Affiliation

Congenica Ltd

ORCID

Career Start Year

1995

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35549752	Unlocking sociocultural and community factors for the global adoption of genomic medicine.	Orphanet J Rare Dis	2022
35549752	Unlocking sociocultural and community factors for the global adoption of genomic medicine.	Orphanet J Rare Dis	2022
33540773	Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.	Cancers (Basel)	2021
33540773	Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.	Cancers (Basel)	2021
33564657	Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?	Biomed Hub	2020
33564664	Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.	Biomed Hub	2020
33564657	Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?	Biomed Hub	2020
33564664	Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.	Biomed Hub	2020
29632381	Plain-language medical vocabulary for precision diagnosis.	Nat Genet	2018
29632381	Plain-language medical vocabulary for precision diagnosis.	Nat Genet	2018
27956199	The path to successful commercialization of cell and gene therapies: empowering patient advocates.	Cytotherapy	2017
31988949	EU Health Policy, Coherence, Stakeholder Diversity and Their Impact on the EMA.	Biomed Hub	2017
31988927	A Disruptive Dinner Guest.	Biomed Hub	2017
28679655	Marketing of unproven stem cell-based interventions: A call to action.	Sci Transl Med	2017
28880017	Will rising prices and budget constraints prevent patients from accessing novel gene therapies?	Gene Ther	2017
28517990	Risk and Benefit in Personalised Medicine: An End User View.	New Bioeth	2017
27956199	The path to successful commercialization of cell and gene therapies: empowering patient advocates.	Cytotherapy	2017
28289980	Implementing genetic education in primary care: the Gen-Equip programme.	J Community Genet	2017
31988949	EU Health Policy, Coherence, Stakeholder Diversity and Their Impact on the EMA.	Biomed Hub	2017
31988927	A Disruptive Dinner Guest.	Biomed Hub	2017
28289980	Implementing genetic education in primary care: the Gen-Equip programme.	J Community Genet	2017
28880017	Will rising prices and budget constraints prevent patients from accessing novel gene therapies?	Gene Ther	2017
28517990	Risk and Benefit in Personalised Medicine: An End User View.	New Bioeth	2017
28679655	Marketing of unproven stem cell-based interventions: A call to action.	Sci Transl Med	2017
27366873	Prevention of Congenital Disorders and Care of Affected Children: A Consensus Statement.	JAMA Pediatr	2016
27366873	Prevention of Congenital Disorders and Care of Affected Children: A Consensus Statement.	JAMA Pediatr	2016
25248395	Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.	Eur J Hum Genet	2015
25248395	Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.	Eur J Hum Genet	2015
24424120	Managing clinically significant findings in research: the UK10K example.	Eur J Hum Genet	2014
25407328	Generating health technology assessment evidence for rare diseases.	Int J Technol Assess Health Care	2014
24424120	Managing clinically significant findings in research: the UK10K example.	Eur J Hum Genet	2014
24801295	Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) Congress: changing the policy landscape: haemophilia patient involvement in healthcare decision-making.	Eur J Haematol Suppl	2014
25407328	Generating health technology assessment evidence for rare diseases.	Int J Technol Assess Health Care	2014
24801295	Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) Congress: changing the policy landscape: haemophilia patient involvement in healthcare decision-making.	Eur J Haematol Suppl	2014
23794314	Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations.	J Community Genet	2013
24285799	Commentary: Patients will need knowledgeable guidance.	BMJ	2013
23794314	Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations.	J Community Genet	2013
24326170	A pilot study of multicriteria decision analysis for valuing orphan medicines.	Value Health	2013
23657386	A P3G generic access agreement for population genomic studies.	Nat Biotechnol	2013
24285799	Commentary: Patients will need knowledgeable guidance.	BMJ	2013
24326170	A pilot study of multicriteria decision analysis for valuing orphan medicines.	Value Health	2013
23657386	A P3G generic access agreement for population genomic studies.	Nat Biotechnol	2013
22582247	Research priorities. ELSI 2.0 for genomics and society.	Science	2012
22582247	Research priorities. ELSI 2.0 for genomics and society.	Science	2012
20942607	Toward a proportionate regulatory framework for gene transfer: a patient group-led initiative.	Hum Gene Ther	2011
20942607	Toward a proportionate regulatory framework for gene transfer: a patient group-led initiative.	Hum Gene Ther	2011
21719093	Safety of medicines and the use of animals in research.	Lancet	2011
21643981	Population biobanks and returning individual research results: mission impossible or new directions?	Hum Genet	2011
21719093	Safety of medicines and the use of animals in research.	Lancet	2011
21643981	Population biobanks and returning individual research results: mission impossible or new directions?	Hum Genet	2011

1 - 50 of 100

Erika Kleiderman

Universite de Montreal.

Career Start Year 2012

Number of shared co-authors 8

Stuart Hogarth

University of Cambridge

Career Start Year 2007

Number of shared co-authors 5

Jennifer B McCormick

Penn State College of Medicine

Career Start Year 2006

Number of shared co-authors 6

Yann Joly

McGill University.

Career Start Year 2003

Number of shared co-authors 29

Amy L McGuire

Baylor College of Medicine.

Career Start Year 2002

Number of shared co-authors 24

Richard R Sharp

Biomedical Ethics, Mayo Clinic and Foundation

Career Start Year 1999

Number of shared co-authors 38

Jeantine E Lunshof

Wyss Institute for Biologically Inspired Engineering, Harvard University

Career Start Year 1999

Number of shared co-authors 5

Bryn Williams-Jones

School of Public Health, Universite de Montreal.

Career Start Year 1999

Number of shared co-authors 0

Debra J H Mathews

Carlsberg Laboratory, Case Western Reserve University, Johns Hopkins Medicine, Johns Hopkins School of Medicine, Johns Hopkins School of Public Health, Johns Hopkins University, National Academy of Sciences, Pennsylvania State University, Presidential Commission for the Study of Bioethical Issues

Career Start Year 1999

Number of shared co-authors 19

David Magnus

Stanford Center for Biomedical Ethics, Stanford University

Career Start Year 1998

Number of shared co-authors 4

Ainsley J Newson

Sydney Health Ethics, Sydney School of Public Health, The University of Sydney

Career Start Year 1997

Number of shared co-authors 3

Daryl Pullman

Memorial University

Career Start Year 1996

Number of shared co-authors 9

Christine Patch

Queen Mary University of London, United Kingdom Society and Ethics Research

Career Start Year 1994

Number of shared co-authors 14

Mats G Hansson

Centre for Research Ethics & Bioethics, Uppsala University

Career Start Year 1993

Number of shared co-authors 8

Karen J Maschke

a nonprofit bioethics research institute

Career Start Year 1993

Number of shared co-authors 4

Anneke Lucassen

Clinical Ethics, University of Oxford

Career Start Year 1992

Number of shared co-authors 18

Jeffrey P Kahn

Berman Institute of Bioethics, Johns Hopkins University

Career Start Year 1991

Number of shared co-authors 9

Benjamin S Wilfond

University of Washington School of Medicine.

Career Start Year 1990

Number of shared co-authors 15

Lisa S Parker

Center for Bioethics & Health Law, University of Pittsburgh

Career Start Year 1990

Number of shared co-authors 3

James P Evans

University of North Carolina

Career Start Year 1989

Number of shared co-authors 13

Henry T Greely

The Center for Law and the Biosciences, Stanford University

Career Start Year 1989

Number of shared co-authors 13

Jeffrey R Botkin

University of Utah

Career Start Year 1988

Number of shared co-authors 9

Barbara A Koenig

University of California-San Francisco.

Career Start Year 1986

Number of shared co-authors 19

Mildred K Cho

Center for Biomedical Ethics, Stanford University School of Medicine

Career Start Year 1985

Number of shared co-authors 14

Susan M Wolf

Law School and Medical School, University of Minnesota

Career Start Year 1984

Number of shared co-authors 9

Mark A Rothstein

University of Louisville

Career Start Year 1983

Number of shared co-authors 11

Dianne Nicol

University of Tasmania

Career Start Year 1982

Number of shared co-authors 10

Thomas H Murray

Yale School of Medicine

Career Start Year 1980

Number of shared co-authors 5

Robert Cook-Deegan

Arizona State University.

Career Start Year 1978

Number of shared co-authors 22

Wylie Burke

The Heart Institute, Cincinnati Children's Hospital Medical Center

Career Start Year 1975

Number of shared co-authors 19

row(s) 1 - 30 of 30

Jane Kaye

University of Oxford

Co-authored papers 4

Bartha Maria Knoppers

McGill University

Co-authored papers 4

Kazuto Kato

Osaka University

Co-authored papers 3

Clement Adebamowo

Institute for Human Virology

Co-authored papers 3

Patricia A Marshall

Case Western Reserve University

Co-authored papers 3

Karen Kennedy

National Cancer Research Institute

Co-authored papers 3

Yangfan Liu

Co-authored papers 2

Marcos Delgado

Co-authored papers 2

Ruth Jamieson

Newcastle University

Co-authored papers 2

John W Belmont

Illumina Inc.

Co-authored papers 2

Alexandre Montpetit

McGill University and Genome Quebec Innovation Centre

Co-authored papers 2

Chris Clee

Co-authored papers 2

Mark F Leppert

University of Utah

Co-authored papers 2

Panos Deloukas

William Harvey Research Institute, Queen Mary University of London

Co-authored papers 2

Fanny Chagnon

McGill University

Co-authored papers 2

Hongbin Zhao

First Hospital of Xingtai

Co-authored papers 2

E Clayton

Harvard Medical School, Vanderbilt University, Yale University Yale Law School

Co-authored papers 2

Jeffrey Barrett

Wellcome Trust Sanger Institute

Co-authored papers 2

Li Jin

Fudan University

Co-authored papers 2

Thomas D Willis

Adaptive Biotechnologies

Co-authored papers 2

Suzanne M Leal

Center for Statistical Genetics, Columbia University Medical Center

Co-authored papers 2

David A Hinds

23andMe Inc.

Co-authored papers 2

Ludmila Pawlikowska

Center for Cerebrovascular Research

Co-authored papers 2

N??ria Malats

Spanish National Cancer Research Centre

Co-authored papers 2

Albert V Smith

University of Michigan School of Public Health ann arbor

Co-authored papers 2

Jun Yu

Beijing Institute of Genomics, Chinese Academy of Sciences

Co-authored papers 2

Jessica Roy

Co-authored papers 2

Jian-Bing Fan

Nanfang Hospital and Basic Medical College, Southern Medical University

Co-authored papers 2

Jean-Fran??ois Olivier

McGill University Health Center

Co-authored papers 2

Robert W Plumb

Co-authored papers 2

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators